iGEN
Visit IGEN World Explore IGEN Expo
EXPLORE UPGRADE PLANS
BREAKING
Burnham Confirms Pragmatic North Sea Oil Stance in Trump Call, Fueling Drilling Debate Leaked Memo Links Iranian Hackers to Minnesota Water Utility Cyberattacks Everyone Is Freaking Out About OpenAI and Anthropic’s Race for Dominance Govt Debunks AI-Generated Fake Video of Finance Minister Nirmala Sitharaman Promoting Investment Scheme UPS Unveils Digital Tools to Attract Small Businesses Amid Strategic Shift from Low-Margin E-Commerce CPKC sets second-quarter revenue record as operating income rises 10% Your Freight Funnel Is Leaking Margin: What Your Reports Won't Show Transponders Off: Saudi Crude Tankers for India Exit Red Sea 'Dark' to Avoid Houthi Blockade Nvidia’s Open Source Alliance Snubs OpenAI and Anthropic, Deepening AI Rift For the First Time, Zoox Can Charge People for Rides in Its Steering-Wheel-Free Robotaxis Burnham Confirms Pragmatic North Sea Oil Stance in Trump Call, Fueling Drilling Debate Leaked Memo Links Iranian Hackers to Minnesota Water Utility Cyberattacks Everyone Is Freaking Out About OpenAI and Anthropic’s Race for Dominance Govt Debunks AI-Generated Fake Video of Finance Minister Nirmala Sitharaman Promoting Investment Scheme UPS Unveils Digital Tools to Attract Small Businesses Amid Strategic Shift from Low-Margin E-Commerce CPKC sets second-quarter revenue record as operating income rises 10% Your Freight Funnel Is Leaking Margin: What Your Reports Won't Show Transponders Off: Saudi Crude Tankers for India Exit Red Sea 'Dark' to Avoid Houthi Blockade Nvidia’s Open Source Alliance Snubs OpenAI and Anthropic, Deepening AI Rift For the First Time, Zoox Can Charge People for Rides in Its Steering-Wheel-Free Robotaxis
Home ›› Topics ›› novo nordisk

Topic

novo nordisk

2 stories
Ozempic-maker Novo Nordisk sues Eli Lilly for false advertising over weight-loss drug claims Manufacturing
Pharmaceuticals #novo nordisk#eli lilly

Ozempic-maker Novo Nordisk sues Eli Lilly for false advertising over weight-loss drug claims

Novo Nordisk has sued Eli Lilly, alleging false advertising in Eli Lilly's campaigns that compare weight-loss and diabetes drugs. Novo claims Eli Lilly intentionally used outdated studies and omitted higher-dose options to create a misleading impression of superiority. The lawsuit seeks to pull the ads and run corrective advertising.

Jul 21, 2026 1 source
Novo Nordisk Reveals Clinical Trials Data Breached in Cyberattack, Patient IDs Exposed Technology
Cybersecurity #cyberattack#data breach

Novo Nordisk Reveals Clinical Trials Data Breached in Cyberattack, Patient IDs Exposed

Novo Nordisk, the maker of Ozempic and Wegovy, confirmed a cyberattack that breached pseudonymized clinical trial data, including patient IDs, biomarkers, and lifestyle factors. The company stated no personally identifiable information (PII) was exposed and core operations remain unaffected. Third-party cybersecurity experts are investigating.

Jun 15, 2026 1 source